Implementing Contemporary Technology and Therapeutic Expertise, Croissance Clinical Research was initiated in 2013, with dedication to helping the client to achieve their ultimate goal. Croissance believes in ensuring that each clinical study is conducted in an ethical and compliant manner that offers the highest possible quality with clean and accurate data, meets international quality standards, cost-effectively on time and every time. Croissance is a full-service CRO offering services like Project management, Capacity building, Medical writing, Safety oversight, Quality assurance, Regulatory support, Clinical Data management and Biostatistics. Croissance is an experienced CRO offering its services for Phase II–IV, PMS, IIS and Epidemiology studies with a large network of investigators in public & private hospitals across India, Nepal, Africa. Croissance is an ISO 9001: 2015 & ISO 27001:2013 certified organization and a strong process-driven company.
Mr. Satish Marukurthi, Founder & CEO at Croissance Clinical Research has been largely involved in building, shaping and providing innovative strategies in the growth story of Croissance. He is a dynamic individual and under his leadership, Croissance grew from an Indian to an International CRO. He has been awarded the most prestigious award of the “Pharma Leaders Innovative Leadership in Clinical Research 2019” at Pharma Leaders Power Brand Awards 2019.
In the last decade, Croissance has successfully delivered 125 clinical trials across different therapeutic areas and has managed data of more than 1.5 million pages. COVID taught the industry how to be agile and how clinical trials can be done in the most efficient ways even in a challenging situation. Croissance played a vital role by supporting multiple pharmaceutical companies in drug development and this war against the good of mankind through adapting to technology and executive clinical trials at the almost quality standards and within the quickest timelines. Over the years Croissance has developed vast experience & and expertise in certain therapeutic areas like Respiratory and Vaccines.
To ensure each clinical study is conducted in ethical and safe manner that offers the highest possible quality with clean and accurate data, meeting international standards cost effectively on time, every time.
Croissance Clinical Research is fueled by morals and principles like providing customer satisfaction with quality and integrity. Collaborating and keeping open communication for constant improvement. Being environmentally responsible, having ethical conduct.
In next 5 years Croissance wants to be seen as a leading CRO in vaccine trials and proudly serve its customer. The future will be digital and the team is turning the table around in terms of formulating the right set of processes, developing required skills, adapting to new technologies and platform that can help them work more efficiently. Focus is to venture newer territories and countries where there is high unmet need for vaccines. Work closely with the government agencies to streamline processes for smooth conduct of trials. Croissance is investing wisely to create an ecosystem that can generate quality real world data in a more efficient manner and help its client meet the study objective.
